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Abstract
Background: Whether the primary care physician's assessment of patient compliance is a valuable prognostic
marker to identify patients who are at increased risk of death, or merely reflects measurement of various
treatment parameters such as HbA1C or other laboratory markers is unclear. The objective of this prospective
cohort study was to investigate the prognostic value of the physicians' assessment of patient compliance and other
factors with respect to all-cause mortality during a one year follow-up period.
Methods: A prospective cohort study was conducted among 1014 patients with type 2 diabetes aged 40 and over
(mean age 69 years, SD 10.4, 45% male) who were under medical treatment in 11 participating practices of family
physicians and internists working in primary care in a defined region in South Germany between April and June
2000. Baseline data were gathered from patients and physicians by standardized questionnaire. The physician's
assessment of patient compliance was assessed by means of a 4-point Likert scale (very good, rather good, rather
bad, very bad). In addition, we carried out a survey among physicians by means of a questionnaire to find out which
aspects for the assessment of patient compliance were of importance to make this assessment. Active follow-up
of patients was conducted after one year to determine mortality.
Results: During the one year follow-up 48 (4.7%) of the 1014 patients died. Among other factors such as patient
type (patients presenting at office, nursing home or visited patients), gender, age and a history of macrovascular
disease, the physician's assessment of patient compliance was an important predictor of all-cause mortality.
Patients whose compliance was assessed by the physician as "very bad" (6%) were significantly more likely to die
during follow-up (OR = 2.67, 95% CI 1.02–6.97) after multivariable adjustment compared to patients whose
compliance was assessed as "rather good" (45%) or "very good" (18%). The HbA1C-value and the cholesterol level
at baseline showed no statistically significant association with all-cause mortality. According to our survey for
most of the physicians self-acceptance of disease, treatment adherence, patient's interest in physician's
explanations, attendance at appointments, a good self-management, and a good physician-patient relationship
were key elements in the assessment of patient compliance.
Conclusion: The primary care physician's assessment of patient compliance is a valuable prognostic marker for
mortality among patients with type 2 diabetes. Identification of patients in need of improved compliance may help
to target preventive measures.
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Background
Type 2 diabetes mellitus (DM) is the most common endo-
crine disease in developed countries and prevalence is
increasing worldwide [1]. In Germany, about 5% of the
population are affected and the prevalence is increasing
dramatically with age [2]. Patients with type 2 diabetes
have an approximately threefold risk for all cardiovascular
diseases [3,4] and their risk of death from all causes is
increased by 75% compared to patients without diabetes.
The morbidity and mortality resulting from complica-
tions of type 2 diabetes such as micro- and macrovascular
disease cause considerable costs for the individual and the
society [2,5] and necessitate special care and attention [6].
It is well known that the likelihood of diabetic complica-
tions, and subsequently risk to die, in patients with diabe-
tes is associated with glycemic control [7-11] and
adherence to treatment and successful self-management.
Whether the physicians' assessment of patient compliance
is a valuable prognostic information to identify patients
who are at increased risk for subsequent complication or
death, or merely reflects measurement of various treat-
ment parameters such as HbA1C or other laboratory mark-
ers is unclear yet. However, as most patients are treated in
primary care setting, this information would be critical
and would eventually allow to identify subjects in need
for improved diabetic therapy and help to target preven-
tive measures.
The objective of this prospective cohort study including
all patients with type 2 diabetes who were under medical
treatment in the primary care practices of family physi-
cians and internists in a geographically defined region was
to investigate various aspects and the prognostic value of
the physicians' assessment of the patient compliance with
respect to all-cause mortality during a one year follow-up
period.
Methods
Study design and study population
We included all patients with known DM type 2, aged 40
and over in a longitudinal study, who were under medical
treatment in one of 11 participating practices of general
practitioners (general practitioners or internists working
in primary care in a coherent region in South Germany)
between April and June 2000. Some surgeries were shared
by 2 GPs, in total 15 physicians were involved. In addition
to the patients who presented themselves in the surgeries
of the general practices we also included all patients who
were seen in care homes or visited at home by the partici-
pating GPs. DM was defined as having ever fulfilled the
following diagnostic criteria: nonfasting blood glucose of
> 200 md/dl or a fasting glucose of ≥ 126 mg/dl according
to the diagnosic criteria of the American Diabetes Associ-
ation.
Data collection
This study was part of the quality assurance program of
the participating practices. All data collection procedures
and diagnostic criteria were defined in a manual and all
practice teams were trained accordingly before study con-
duct. All patients who presented at the surgeries of the GPs
were asked to fill out a standardized questionnaire which
contained information about medical history, life style
habits, and health related quality of life. The physicians
filled out a separate questionnaire with details to diagno-
sis of DM, treatment, existing comorbidity (as docu-
mented in the patient's charts), most recent laboratory
results and other patient related information for patients
presenting at the surgeries as well as for the patients who
were seen in nursing homes or visited at home. Participa-
tion was voluntary and all information was collected
anonymously at the time of the patient's office visit. The
informed consent of the patient was documented on the
physician's questionnaire. The study has been carried out
in compliance with the Helsinki Declaration.
Each physician was asked to assess the compliance of each
patient by the following question: "How would you assess
the compliance of this patient?" The answer was asked on
a four point Likert scale (very good, rather good, rather
bad, very bad). In addition, after all patients had been
included, we carried out a qualitative survey among phy-
sicians by means of a standardized questionnaire to find
out which aspects for the assessment of patient compli-
ance were of strong or very strong importance to make this
assessment. The physicians were asked at the end of the
study what meaning the following ten statements had for
them in general when answering the question related to
patients' compliance: 1) "The patient seems to have no
self-acceptance of his disease"; 2) "The patient shows no
interest in my explanations and councelings"; 3) "The
patient keeps re-appointments only sporadicly"; 4) "The
patient is adherent to the recommended treatment"; 5)
"The patient has poor social or family support"; 6) The
patient often has a high HbA1C-value"; 7) "The patient has
a good self-management"; 8) "The patient has many other
concurrent diseases"; 9) "The patient has a bad health-
related quality of life"; 10) "The physician-patient rela-
tionship is bad". For every question the following
response was possible on a four-point Likert scale ("very
important meaning, rather important meaning, rather less
important meaning, no importance").
HbA1C of all participating patients was measured as part of
the routine medical care in the same laboratory by means
of High Performance Liquid Chromatographie (HPLC)
on a Tosoh HLC 723 and total cholesterol concentrations
were determined by routine enzymatic methods.BMC Family Practice 2006, 7:42 http://www.biomedcentral.com/1471-2296/7/42
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One year after the inclusion in this study, patients' mortal-
ity was recorded by the 11 practices. For all 1014 included
patients information on mortality (dead/alive at follow-
up) could be obtained.
Statistical analysis
The study population is presented in a descriptive way. In
addition, we determined the association of various per-
sonal, sociodemographic, life style, medical and labora-
tory characteristics (a HbA1C  value  ≥ 8%, a total
cholesterol value of ≥ 257 mg/dl (≥ 8th percentile)), and of
physician's assessment of patient compliance with all-
cause mortality and used a χ2-test to assess the signifi-
cance of the associations.
We then used multivariable logistic regression with a
backward variable selection procedure to identify the
independent association of various factors with all-cause
mortality. The following variables were considered for the
initial model: gender (male, female), patient type
(patients presenting at office, nursing home or visited
patients), age (decades), family status (single, married,
widowed, divorced), time since diagnosis of diabetes (< 1
year, 1 to 4 years, 5 to 10 years, > 10 years), macrovascular
complications (myocardial infarction, apoplex, or phe-
ripheral arterial vascular disease), microvascular compli-
cations (retinopathy, nephropathy, latter defined by
microalbuminuria (neuropathological complications not
included as they were difficult to assess in the context of
this study in primary care)), HbA1C-value (continuous),
total cholesterol (continuous), prescription of ACE-medi-
cation or lipid-lowering drugs, the blood pressure values
from baseline, patient compliance (physicians' assess-
ment) (very good, rather good, rather bad, very bad).
We then eliminated step by step all variables which did
not contribute to the model in a statistically significant
way (p > 0.1). Odds ratios (OR) and 95% confidence
intervals were calculated for all variables included in the
final model.
Results
In total, 1014 patients with known DM aged 40 and over
were included in this study. Response among all eligible
patients with DM was 88%. 882 (87%) of the patients pre-
sented themselves in the 11 participating general practices
and 132 (13%) were seen in nursing homes or visited at
home by the physicians.
As table 1 shows, 55% of the patients with DM were
women. Mean age of patients with DM was 69.0 years (SD
10.4, range 40 to 91 years), two thirds of them (66%)
were between 60 and 80 years old, and 65% were married.
The time since diagnosis was less than 5 years among 34%
of patients, 5 to 10 years among 32% of patients, and
more than 10 years among 30% of patients. The physi-
cians' assessment of patient compliance was in general
more favourable for the patients presenting at the surgery.
Overall, 18% of patients were judged as "very good", 45%
as "rather good", 31% as "rather bad", and 6% as "very
bad" regarding their compliance.
During the one year follow-up period 48 (4.7%) of the
patients died. Table 2 shows the all-cause mortality
according to various factors. Mortality was much higher in
patients visited in nursing homes or at home compared to
patients presenting at the surgery (18.2% vs. 2.7%. In
bivariate analysis gender was not associated with all cause
mortality. However, mortality strongly increased with age
and was highest in widowed subjects. Time since diagno-
sis of DM, and presence of macrovascular or microvascu-
lar complications at baseline were clearly associated with
a higher proportion of subjects who died during follow-
up.
The physicians' assessment of patient compliance during
baseline was also associated with an increased mortality
(see table 3). Patients who's compliance was judged at
baseline as "very bad" showed a 1-year mortality of 13.1%
compared to a 1-year mortality of 4.2% ("rather bad"),
3.8% ("rather good"), and 4.0% ("very good") in the
respective categories (p = 0.01). By contrast, a high HbA1C-
value (≥ 8%) and a cholesterol value ≥ 257 mg/dl (≥ 8th
percentile) at baseline showed no statistically significant
association with all-cause mortality during the one year
follow-up (see table 3).
We then used unconditional logistic regression and a step-
wise backward selection procedure to find the most parsi-
monious model of factors associated with all-cause-
mortality (see table 4). Patients seen at nursing homes or
visited at home had a higher odds to die within the fol-
low-up period compared to patients presenting at the sur-
gery (OR 3.92, 95% CI 1.85–8.30). In addition, female
patients showed significantly lower odds to die compared
to males (OR 0.34; 95% CI 0.17–0.67). In addition, there
was a clear increased risk to die with increasing age. Fur-
thermore, the presence of macrovascular complications
was a statistically significant determinant of subsequent
risk to die (OR 3.17, 95% CI 1.57–6.39). The physicians'
assessment of the patient compliance was also an impor-
tant factor associated with all-cause mortality. Patients
whose compliance was assessed as "very bad" had an OR
of 2.67 (95% 1.02–6.97) compared to patients assessed as
"very good" or "rather good". The fit of the model did not
improve and the observed association did not change if
HbA1C-values, total cholesterol, prescription of ACE-med-
ication or lipid-lowering drugs, or the blood pressure val-
ues from baseline were added in the model (data notBMC Family Practice 2006, 7:42 http://www.biomedcentral.com/1471-2296/7/42
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shown). None of the latter four variables met the criteria
for inclusion in the model.
Finally, we carried out a small survey among the fifteen
physicians to find out which aspects of compliance were
most important for them when making this assessment
on a individual basis. For most of them self-acceptance of
disease, treatment adherence, patient's interest in physi-
cian's explanations, attendance at appointments, a good
self-management, and a good physician-patient relation-
ship were key elements. Patient's co-morbidity, a high
HbA1C value, a good social support, and quality of health
related life were other, sometimes less important elements
in their decision making.
Discussion
In this study physicians' assessment of patient compliance
was found to have an independent prognostic value for
subsequent risk of death, which persisted after control for
other factors. Compliance may reflect many aspects of
Table 1: Sociodemographic and medical characteristics of study population at baseline
Patients presenting at office Care home or visited patients All
n8 8 2 1 3 2 1 0 1 4
na %n a %n a %
Gender
-  M a l e 4 2 4 4 83 42 54 5 8 4 5
-  F e m a l e 4 5 3 5 29 87 55 5 1 5 5
Age (years)
Mean (SD) 67.3 (9.6) 80.1 (8.6) 69.0 (10.4)
-  4 0  –  4 9 3 8 4113 9 4
- 50 – 59 173 20 2 2 175 17
- 60 – 69 331 38 11 8 342 34
- 70 – 79 272 31 52 39 324 32
- 80 + 65 7 66 50 131 13
Family status
-  s i n g l e 3 64 1 41 15 05
- married 593 72 34 26 627 65
- widowed 168 20 78 59 246 26
-  d i v o r c e d 3 0 4543 0 4
Time since 
diagnosis of 
Diabetes (years)
<  1  y e a r 6 8 8327 1 7
1 to 4 years 246 28 24 19 270 27
5 to 10 years 288 33 40 30 328 32
> 10 years 246 28 59 44 305 30
u n k n o w n 3 4 4654 0 4
Diabetes 
medication
-  D i e t  o n l y 2 8 2 3 24 83 63 3 0 3 2
- Medication 
(Combinations 
possible)
-  I n s u l i n 1 9 4 2 25 03 82 4 4 2 5
- 
Sulfonylurea
s
3 3 2 3 83 82 93 7 0 3 6
- Metformin 304 34 14 11 318 31
Patient 
compliance 
(physicians' 
assessment)
- very good 164 19 11 9 175 18
- rather good 403 46 48 38 451 45
- rather bad 255 29 52 41 307 31
- very bad 46 5 15 12 61 6
a numbers do not always add up to total due to missing information in few itemsBMC Family Practice 2006, 7:42 http://www.biomedcentral.com/1471-2296/7/42
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successful self-management of diabetes and the identifica-
tion of patients in need of improved compliance may help
to target preventive measures.
It is well accepted that an optimal glucose control, adher-
ence to a treatment regimen, and successful self-manage-
ment minimizes the likelihood of diabetic complications,
and subsequently, the risk of death [7-11]. However,
many different components seem to be related to success-
ful self-management of this chronic disease; provider
characteristics, the patient-physician relationship, and
patients' personal characteristics and beliefs, as well as
environmental, social, and cultural factors act as impor-
tant contributors to this complex issue [12]. Although
physicians' assessment of patient compliance appears to
be strongly related with glycemic control [13], its prog-
nostic value was found to be independent of glycemic
control in this study and prognostically more relevant
than gylcemic control.
The key element in management of chronic diseases is
self-management. Unfortunately, many patients are not
willing or able to take full responsibility for their care
[14]. Successful treatment should be regarded as a team
approach, incorporating patients, care givers and family
members and the social context of the individual [15].
Factors such as a good team spirit in medical practice can
improve management of patients with chronic diseases
[16]. However, attempts to increase the frequency of
appointments or the use of other measures in patients
with poor compliance may be counterproductive. Many
of these patients will react with even more resistance. A
promising approach may be to strengthen the "sense of
coherence" by taking aspects of comprehensibility, man-
ageability and meaningfulness from the patients' social
Table 2: All cause mortality according to various sociodemographic and medical factors
Died during follow-up
(n/N)a %p - v a l u e
Total 48/1014 4.7
Patient type
- Patients presenting at office 24/882 2.7
- Care home or visited patients 24/132 18.2 < 0.0001
Gender
- Male 26/458 5.7
- Female 22/551 4.0 0.2
Age (years)
- 40 – 59 1/214 4.7
- 60 – 69 9/342 2.6
- 70 – 79 16/324 4.9
- 80 + 22/131 16.8 < 0.0001b
Family status
- single 4/50 8.0
- married 22/626 3.5
- widowed 22/246 8.9
- divorced 0/34 0 0.004b
Time since diagnosis of 
diabetes (years)
- < 1 year 0/71 0
- 1 to 4 years 9/270 3.3
- 5 to 10 years 17/328 5.2
- > 10 years 21/305 6.9 0.04b
Macrovascular complications 
at baseline
- no 12/625 1.9
- yes 36/398 9.3 < 0.0001
Microvascular complications 
at baselinec
- no 25/718 3.5
- yes 23/296 7.8 0.005
a numbers do not always add up to total due to missing information in few items
b Fisher's Exact Test
c (neuropathological complications not included as difficult to assess in the context of this study in primary care)BMC Family Practice 2006, 7:42 http://www.biomedcentral.com/1471-2296/7/42
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and personal perspective into account [17]. As earlier
work suggested individual differences in perceived control
and coping strategies may strongly interact with manage-
ment of chronic diseases [18]. However, clearly more
studies especially in primary care setting are needed to fur-
ther determine which factors pose obstacles to an integra-
tive conception of a successful treatment of chronic
diseases and what compliance means from the physician's
as well as the patient's view. As shown by the cross-
national Diabetes Attitudes, Wishes and Needs (DAWN)
study, psychosocial problems in patients with diabetes are
common according to reports of patients and providers,
and are perceived as important barriers to effective self-
care. The regimen adherence of patients was less than
optimal in all ten participating countries (Germany
included) and the providers believed that mainly psycho-
logical problems were the cause. However, providers also
reported that they often do not have the critical resources
for addressing these problems [19].
If looking at the results of this study the following
strengths and weaknesses should be considered: Rela-
tively few patients were assessed as having a "very bad"
compliance and only for this group the prognostic rele-
vance was evident. Unfortunately, we had no comparison
with another related sample or norm groups. Further-
Table 3: All cause mortality according to physicians' assessment of patient's compliance and various laboratory markers at baseline
Died during follow-up
(n/N)a %p - v a l u e
Total 48/1014 4.7
Patient compliance 
(physicians' assessment)
- very good 7/175 4.0
- rather good 17/451 3.8
- rather bad 13/307 4.2
- very bad 8/61 13.1 0.01
HbA1C-value
- < 8% 32/766 4.2
- ≥ 8% 12/208 5.8 0.32
Total cholesterol
- < 257 mg/dl 40/789 3.0
- ≥ 257 mg/dl (≥ 80th percentile) 6/199 5.1 0.22
a numbers do not always add up to total due to missing information in few items
Table 4: Variables found to be independently associated with all-cause mortality: results of multivariable logistic regression (all 
variables controlled for each other)
Characteristic Odds ratio and (95% CI) controlled for 
covariates
p-value
Patient compliance (physicians' 
assessment)
- very good or rather good 1Reference
- rather bad 0.78 (0.38–1.61) 0.50
- very bad 2.67 (1.02–6.97) 0.04
Patient type
- Patients presenting at office 1Reference
- Nursing home or visited patients 3.92 (1.85–8.30) 0.0004
Gender
- Male 1Reference
- Female 0.34 (0.17–0.67) 0.002
Age (years)
- 40 – 59 1Reference
- 60 – 69 4.79 (0.59–38.67) 0.14
- 70 – 79 7.98 (1.01–63.16) 0.05
- 80 + 20.46 (2.47–169.45) 0.005
Macrovascular complications
- no 1Reference
- yes 3.17 (1.57–6.39) 0.001BMC Family Practice 2006, 7:42 http://www.biomedcentral.com/1471-2296/7/42
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more, we did not measure a specific component of com-
pliance such as treatment adherence (e.g. pills counts) or
the compliance with a special diet. However, we measured
physicians' assessment of the patient compliance as an
integrative measure (including also aspects of self-man-
agement behaviour) and from our small qualitative sur-
vey among the physicians we got important clues which
aspects of compliance were most important for them
when making this assessment on an individual basis.
Notably, outcome parameters such as HbA1C, the social
network, and the health related quality of life were less
important elements in their decision making with respect
to assessment of patient compliance.
This study was conducted in the framework of a quality
assurance program of the participating practices including
all patients within a defined geographic region, irrespec-
tive of their insurance affiliation. As in Germany almost
all patients have access to health care, as all primary care
physicians within a coherent region participated, and as
most patients with DM usually consult their primary care
giver once in three months, we are confident that the
study population comprised almost all patients with type
2 DM in primary medical care in the study region. How-
ever, patients not seeking medical care and patients hospi-
talized were certainly underrepresented in this study.
Conclusion
Having the aforementioned caveats in mind, our study
suggests that the primary care physician's assessment of
patient compliance is a valuable prognostic marker for the
risk of subsequent death among patients with type 2 dia-
betes. Identification of patients in need of efforts to
improve compliance may help to target preventive meas-
ures.
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